Endometrial ablation is a procedure to surgically destroy the endometrial layers or uterine lining without removing reproductive organ. Heavy menstrual bleeding may arise due to hormonal imbalance, uterine fibroids and polyps, infections of the uterus and cervix, bleeding disorders, and uterine cancer. Endometrial ablation is non-hormonal, minimally invasive procedure alternative to hysterectomy for abnormal uterine bleeding such as menorrhagia. It is used when the heavy bleeding is not controlled by medications and/or hormonal treatments. This is an outpatient procedure and offers low complications and high efficacy rates as compared to other surgical procedures. It is mostly performed among the women who would not wish to have children in future as it may reduce the chances of getting pregnant. This is because the lining that helps fetus to grow are removed during the procedure. Therefore this procedure cannot be performed in pregnancy.
Download Free exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14318
Endometrial ablation is an emerging method and mostly preferred over other surgical procedures among women with abnormal uterine bleeding. Moreover, it is observed that women with high risk of heavy menstrual bleeding opts for endometrial ablation to ensure quality and safety treatment option. Endometrial ablation has been shown to be less costly in both the short term and at five years treatment plan as compared to hysterectomy (abdominal, laparoscopic and vaginal). . Due to short turnaround time and speedy recovery endometrial ablation is preferred by many physicians worldwide. Endometrial ablation can be performed under local anesthetic and takes only few minutes to perform thye surgery and thereby reduces the patient’s stress and discomfort. Although, this is considered as a preferable procedure over hysterectomy, dilatation and curettage, however it also possesses certain risk factors such as perforation of the uterus (accidental puncture), thermal injury to uterus, cervical laceration. It is observed that the above mentioned problems are persists among less number of patient however proper treatment and guidance may overcome the situation. Younger women with heavy bleeding may not opt for endometrial ablation as there are high chances of recurrence in younger women.
A variety of endometrial ablation techniques and devices have been evaluated and used to perform surgery. The procedures initially developed are usually referred to as first-generation devices. In recent times it is observed that second generation devices such as thermal balloon ablation and bipolar ablation are more popular among people. The Endometrial ablation market has been segmented by device type, technology, and geography. By device type, market can be segmented as first generation, balloon ablation and bipolar ablation devices. Based on technology the market has been segmented into, microwave technology, cryotherapy technology, radiofrequency technology, thermal technology, ultrasound technology, hydromechanical technology, electrical technology, light technology, and radiation technology. The global endometrial ablation market is driven by the aging population, as heavy menstrual bleeding is majorly observed among geriatric females. Technological advancement towards minimally invasive surgical devices would also derive the global market demand for endometrial ablation market.
Geographically the market can be segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America contributed the largest share of endometrial ablation market due to increasing healthcare awareness and technological advancement in the region. Followed by Europe contributed the second largest share to endometrial ablation market growth with aging European population. However, Asia Pacific region is expected to be the fastest growing market due to the gradual adoption of improved, next-generation technologies, emerging health care infrastructures, and raising population susceptible to various diseases/conditions.
The key players operating in the endometrial ablation market includes Hologic, Inc., Olympus Corporation, Ethicon US, LLC., Bioteque America Inc., KARL STORZ GmbH & Co. KG, Boston Scientific Corporation, Smith & Nephew plc., CooperSurgical Inc., and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.